News / Information - Zofran 4 mg Tablets UD Discontinuation
Aug 29, 2011
Discontinuation of NDC 0173-0446-02
Effective immediately, GlaxoSmithKline (GSK) will discontinue Zofran (ondansetron hydrochloride) Tablets 4 mg Unit Dose 100s.
This website is funded and developed by GSK. This site is intended for US healthcare professionals only.
Trademarks are owned by or licensed to the GSK group of companies.
©2019 GSK group of companies or its licensor. Produced in USA.